162 related articles for article (PubMed ID: 8344147)
1. Drugs affecting 5-hydroxytryptamine function.
Drug Ther Bull; 1993 Mar; 31(7):25-7. PubMed ID: 8344147
[No Abstract] [Full Text] [Related]
2. [Serotoninergic receptors: physiological and therapeutic implications].
del Río J; Lasheras B
Rev Med Univ Navarra; 1993; 38(3):29-38. PubMed ID: 8134752
[No Abstract] [Full Text] [Related]
3. Serotonin receptors and therapeutics.
Launay JM; Callebert J; Bondoux D; Loric S; Maroteaux L
Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):327-36. PubMed ID: 7522716
[TBL] [Abstract][Full Text] [Related]
4. A pharmacological analysis of an associative learning task: 5-HT(1) to 5-HT(7) receptor subtypes function on a pavlovian/instrumental autoshaped memory.
Meneses A
Learn Mem; 2003; 10(5):363-72. PubMed ID: 14557609
[TBL] [Abstract][Full Text] [Related]
5. Serotonergic mechanisms and current and future psychiatric practice.
Dubovsky SL; Thomas M
J Clin Psychiatry; 1995; 56 Suppl 2():38-48. PubMed ID: 7844106
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology of serotonin as related to anesthesia.
Gyermek L
J Clin Anesth; 1996 Aug; 8(5):402-25. PubMed ID: 8832453
[TBL] [Abstract][Full Text] [Related]
7. Clarifications on the effects of 5-HT1A agonists and selective 5-HT reuptake inhibitors on the 5-HT system.
Blier P; de Montigny C
Neuropsychopharmacology; 1996 Aug; 15(2):213-6. PubMed ID: 8840358
[No Abstract] [Full Text] [Related]
8. Role and localization of serotonin-5HT2 receptors.
Leysen JE; Schotte A
Prog Histochem Cytochem; 1992; 26(1-4):241-9. PubMed ID: 1484964
[No Abstract] [Full Text] [Related]
9. Serotonin receptor subtypes in depression: evidence from studies in neuroendocrine regulation.
Cowen PJ
Clin Neuropharmacol; 1993; 16 Suppl 3():S6-18. PubMed ID: 8131155
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of hippocampal 5-HT synthesis by fluoxetine and paroxetine: evidence for the involvement of both 5-HT1A and 5-HT1B/D autoreceptors.
Barton CL; Hutson PH
Synapse; 1999 Jan; 31(1):13-9. PubMed ID: 10025679
[TBL] [Abstract][Full Text] [Related]
11. Role of somatodendritic 5-HT autoreceptors in modulating 5-HT neurotransmission.
Blier P; Piñeyro G; el Mansari M; Bergeron R; de Montigny C
Ann N Y Acad Sci; 1998 Dec; 861():204-16. PubMed ID: 9928258
[TBL] [Abstract][Full Text] [Related]
12. Induction and maintenance of ganglionic long-term potentiation require activation of 5-hydroxytryptamine (5-HT3) receptors.
Alkadhi KA; Salgado-Commissariat D; Hogan YH; Akpaudo SB
J Physiol; 1996 Oct; 496 ( Pt 2)(Pt 2):479-89. PubMed ID: 8910231
[TBL] [Abstract][Full Text] [Related]
13. The mouse 5-HT2B receptor: possible involvement in trophic functions of serotonin.
Choi DS; Colas JF; Kellermann O; Loric S; Launay JM; Rosay P; Maroteaux L
Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):403-11. PubMed ID: 7920184
[TBL] [Abstract][Full Text] [Related]
14. Effects of various serotonergic agents on alcohol intake and alcohol preference in Wistar rats selected at two different levels of alcohol preference.
Meert TF
Alcohol Alcohol; 1993 Mar; 28(2):157-70. PubMed ID: 8517886
[TBL] [Abstract][Full Text] [Related]
15. The mechanism by which the selective 5-HT1A receptor antagonist S-(-) UH 301 produces head-twitches in mice.
Darmani NA; Reeves SL
Pharmacol Biochem Behav; 1996 Sep; 55(1):1-10. PubMed ID: 8870031
[TBL] [Abstract][Full Text] [Related]
16. Role of 5-hydroxytryptamine1B receptors and 5-hydroxytryptamine uptake inhibition in the cocaine-evoked discriminative stimulus effects in rats.
Filip M; Nowak E; Papla I; Przegaliński E
J Physiol Pharmacol; 2001 Jun; 52(2):249-63. PubMed ID: 11453104
[TBL] [Abstract][Full Text] [Related]
17. Modifications of the serotonergic system in mice lacking serotonin transporters: an in vivo electrophysiological study.
Gobbi G; Murphy DL; Lesch K; Blier P
J Pharmacol Exp Ther; 2001 Mar; 296(3):987-95. PubMed ID: 11181933
[TBL] [Abstract][Full Text] [Related]
18. Modulation of dialysate levels of dopamine, noradrenaline, and serotonin (5-HT) in the frontal cortex of freely-moving rats by (-)-pindolol alone and in association with 5-HT reuptake inhibitors: comparative roles of beta-adrenergic, 5-HT1A, and 5-HT1B receptors.
Gobert A; Millan MJ
Neuropsychopharmacology; 1999 Aug; 21(2):268-84. PubMed ID: 10432475
[TBL] [Abstract][Full Text] [Related]
19. The 5-HT2C receptor as a target for mood disorders.
Serretti A; Artioli P; De Ronchi D
Expert Opin Ther Targets; 2004 Feb; 8(1):15-23. PubMed ID: 14996615
[TBL] [Abstract][Full Text] [Related]
20. Serotonin dysfunction syndromes: a functional common denominator for classification of depression, anxiety, and obsessive-compulsive disorder.
Benkert O; Wetzel H; Szegedi A
Int Clin Psychopharmacol; 1993 Sep; 8 Suppl 1():3-14. PubMed ID: 8254151
[No Abstract] [Full Text] [Related]
[Next] [New Search]
